
← Oh, My Health...There Is Hope!17 oct. · 27 min
Stem Cells: A New Hope in Cancer and Regenerative Medicine with Dr. Drew & Jen Taylor
"I really do think the reason why I am healthy today is I was lucky enough to have a Drew." - Jen Taylor
Dr. Drew Taylor is a co-founder and CEO of Acorn Biolabs, a regenerative medicine company focused on preserving younger hair follicle stem cells for future use. With a PhD in Biomedical Engineering from the University of Toronto, he bridges science, aesthetics, and longevity through cell-based therapies. Dr. Taylor has a background as a professional baseball player, further enriching his performance-driven approach to science and business. He and his wife Jen live with their three sons and are committed to inspiring health and longevity in their community.
Jen Taylor is Dr. Drew Taylor's wife, an integral part of Acorn Biolabs from its inception, contributing to its growth while managing the challenges of raising their family. Her experience battling and overcoming triple negative breast cancer has inspired Acorn's expanded research into cancer treatments using stem cells.
Episode Summary: In this inspiring episode of "All My Health, There Is Hope," host Jana Short welcomes Dr. Drew Taylor and his wife Jen Taylor to discuss the cutting-edge advancements in regenerative medicine spearheaded by their company, Acorn Biolabs. The episode takes an emotional turn as Jen shares her personal battle with triple negative breast cancer, revealing how this experience has shaped Acorn's commitment to advancing cancer treatment through stem cell preservation and therapy.
The Taylors delve into the transformative potential of using one's own stem cells, preserved from a younger age, to address a range of health issues, from skin rejuvenation to cancer. Dr. Drew outlines the process of storing these cells and discusses ongoing research on reprogramming them into different therapeutic applications, including orthopedics, fertility, and internal medicine. The couple also touches upon the surprising simplicity of preserving stem cells and the vast implications it holds for personal health insurance in the future.
Key Takeaways: Jen Taylor's successful battle with triple negative breast cancer motivated Acorn's research into leveraging stem cells for cancer treatment.
Stem cell preservation serves as a 'biological health insurance policy,' offering future opportunities for personalized medical treatments.
The Taylors emphasize the safety and effectiveness of using one's own cells compared to donor stem cells.
Acorn Biolabs uses innovative techniques like CRI